Caprienzymes Technology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
- Revenue Growth 630.90%
- Profit Growth 147.72%
- Ebitda -14.45%
- Net Worth 38.82%
- Total Assets 183.87%
About Caprienzymes Technology
Caprienzymes Technology Private Limited (CTPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 September 2017 (Seven years and four months 7 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Mahalakshmi Venkatachalam and Avinnash Ravindran serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U93090TN2017PTC118867
-
Company No.
118867
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Sep 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Caprienzymes Technology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahalakshmi Venkatachalam
|
Director | 28-Sep-2017 | Current |
|
Avinnash Ravindran
|
Director | 01-Oct-2019 | Current |
Financial Performance of Caprienzymes Technology.
Caprienzymes Technology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 630.9% increase. The company also saw a substantial improvement in profitability, with a 147.72% increase in profit. The company's net worth Soared by an impressive increase of 38.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caprienzymes Technology?
In 2019, Caprienzymes Technology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2020 | Others | ₹0.50 M | Open |
How Many Employees Work at Caprienzymes Technology?
Unlock and access historical data on people associated with Caprienzymes Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caprienzymes Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caprienzymes Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
